Maria Sitarou

582 total citations
15 papers, 261 citations indexed

About

Maria Sitarou is a scholar working on Genetics, Molecular Biology and Hematology. According to data from OpenAlex, Maria Sitarou has authored 15 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Genetics, 7 papers in Molecular Biology and 7 papers in Hematology. Recurrent topics in Maria Sitarou's work include Hemoglobinopathies and Related Disorders (9 papers), Iron Metabolism and Disorders (5 papers) and CRISPR and Genetic Engineering (4 papers). Maria Sitarou is often cited by papers focused on Hemoglobinopathies and Related Disorders (9 papers), Iron Metabolism and Disorders (5 papers) and CRISPR and Genetic Engineering (4 papers). Maria Sitarou collaborates with scholars based in Cyprus, United Kingdom and Japan. Maria Sitarou's co-authors include Michael Hadjigavriel, Soteroula Christou, Paul Telfer, Pietro G. Coen, Michael Angastiniotis, Marina Kleanthous, Carsten W. Lederer, Nicos Skordis, Meropi Toumba and Pavlos Fanis and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and International Journal of Molecular Sciences.

In The Last Decade

Maria Sitarou

15 papers receiving 241 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maria Sitarou Cyprus 7 214 172 68 52 21 15 261
Fen Lin China 9 172 0.8× 133 0.8× 163 2.4× 59 1.1× 24 1.1× 36 315
Iswari Setianingsih Indonesia 9 238 1.1× 205 1.2× 74 1.1× 77 1.5× 26 1.2× 25 314
Deogratius Soka Tanzania 7 473 2.2× 420 2.4× 179 2.6× 52 1.0× 28 1.3× 15 520
Michele Rizzo Italy 7 270 1.3× 256 1.5× 63 0.9× 14 0.3× 10 0.5× 14 330
Filippo Cassarà Italy 7 127 0.6× 114 0.7× 59 0.9× 14 0.3× 22 1.0× 21 164
Milena Magalhães Aleluia Brazil 10 217 1.0× 170 1.0× 20 0.3× 58 1.1× 7 0.3× 29 272
Xing-Mei Xie China 10 262 1.2× 224 1.3× 84 1.2× 38 0.7× 22 1.0× 42 318
Mahin Azimi United States 6 333 1.6× 283 1.6× 130 1.9× 27 0.5× 25 1.2× 11 357
Angela Allen United Kingdom 10 217 1.0× 207 1.2× 40 0.6× 17 0.3× 13 0.6× 28 290
A. Gorakshakar India 11 324 1.5× 298 1.7× 100 1.5× 26 0.5× 42 2.0× 19 410

Countries citing papers authored by Maria Sitarou

Since Specialization
Citations

This map shows the geographic impact of Maria Sitarou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maria Sitarou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maria Sitarou more than expected).

Fields of papers citing papers by Maria Sitarou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maria Sitarou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maria Sitarou. The network helps show where Maria Sitarou may publish in the future.

Co-authorship network of co-authors of Maria Sitarou

This figure shows the co-authorship network connecting the top 25 collaborators of Maria Sitarou. A scholar is included among the top collaborators of Maria Sitarou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maria Sitarou. Maria Sitarou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Tomazou, Marios, et al.. (2024). Context base editing for splice correction of IVSI-110 β-thalassemia. Molecular Therapy — Nucleic Acids. 35(2). 102183–102183. 5 indexed citations
2.
Stephanou, Coralea, Maria Sitarou, Soteroula Christou, et al.. (2023). Evaluation of Mono- and Bi-Functional GLOBE-Based Vectors for Therapy of β-Thalassemia by HBBAS3 Gene Addition and Mutation-Specific RNA Interference. Cells. 12(24). 2848–2848. 1 indexed citations
3.
Kurita, Ryo, Yukio Nakamura, Soteroula Christou, et al.. (2023). High-efficiency editing in hematopoietic stem cells and the HUDEP-2 cell line based on in vitro mRNA synthesis. SHILAP Revista de lepidopterología. 5. 1141618–1141618. 2 indexed citations
4.
Kurita, Ryo, et al.. (2021). Distinct miRNA Signatures and Networks Discern Fetal from Adult Erythroid Differentiation and Primary from Immortalized Erythroid Cells. International Journal of Molecular Sciences. 22(7). 3626–3626. 12 indexed citations
5.
Kountouris, Petros, Kyriaki Michailidou, Soteroula Christou, et al.. (2020). Effect of HBB genotype on survival in a cohort of transfusion-dependent thalassemia patients in Cyprus. Haematologica. 106(9). 2458–2468. 9 indexed citations
6.
Phylactides, Marios, Eleni Katsantoni, Konstantinos Vougas, et al.. (2020). Proteomic Studies for the Investigation of γ-Globin Induction by Decitabine in Human Primary Erythroid Progenitor Cultures. Journal of Clinical Medicine. 9(1). 134–134. 3 indexed citations
7.
Sitarou, Maria, et al.. (2020). Relative and Absolute Quantification of Aberrant and Normal Splice Variants in HBBIVSI−110 (G > A) β-Thalassemia. International Journal of Molecular Sciences. 21(18). 6671–6671. 5 indexed citations
8.
Telfer, Paul, et al.. (2019). PF785 CHANGING CAUSES OF MORTALITY IN TDT DURING THE ERA OF ORAL CHELATION THERAPY FROM 2000 TO 2018. HemaSphere. 3(S1). 346–347. 4 indexed citations
9.
Mussolino, Claudio, Annita Kolnagou, Soteroula Christou, et al.. (2019). The Scope for Thalassemia Gene Therapy by Disruption of Aberrant Regulatory Elements. Journal of Clinical Medicine. 8(11). 1959–1959. 12 indexed citations
10.
Fanis, Pavlos, Ioanna Kousiappa, Marios Phylactides, et al.. (2019). A novel mutation in the erythroid transcription factor KLF1 is likely responsible for ameliorating β‐thalassemia major. Human Mutation. 40(10). 1768–1780. 12 indexed citations
11.
Dijk, Thamar B. van, Coralea Stephanou, Ryo Kurita, et al.. (2018). Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies. Human Gene Therapy Methods. 29(1). 60–74. 13 indexed citations
12.
Lederer, Carsten W., George A. Tanteles, Carolina Sismani, et al.. (2016). Hb A2 Episkopi – a novel δ-globin chain variant [HBD:c.428C>T] in a family of mixed Cypriot–Lebanese descent. Hematology. 22(5). 304–309. 1 indexed citations
13.
Grady, Robert W., Maria Sitarou, Renzo Galanello, et al.. (2007). Efficacy of the Novel Oral Iron Chelator Deferitrin in Metabolic Iron Balance Studies.. Blood. 110(11). 2775–2775. 1 indexed citations
14.
Telfer, Paul, Pietro G. Coen, Soteroula Christou, et al.. (2006). Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004.. PubMed. 91(9). 1187–92. 145 indexed citations
15.
Skordis, Nicos, et al.. (2004). Update on fertility in thalassaemia major.. PubMed. 2 Suppl 2. 296–302. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026